
Shoulder & Elbow
Bupivacaine infusion pumps non-superior to placebo for analgesia after rotator cuff repair
Arthroscopy. 2008 Apr;24(4):397-402. Epub 2008 Jan 7.60 patients undergoing arthroscopic rotator cuff repair received a bolus injection of 35 mL of 0.25% bupivacaine with 1:200,000 epinephrine in the subacromial space at surgical closure. Afterwards, they were randomized to receive either 0.25% bupivacaine at 2 mL/hr, 0.25% bupivacaine at 5 mL/hr, or saline (placebo) at 5 mL/hr via infusion pump, in order to assess the effectiveness of infusion pumps in lowering post-operative pain. Following evaluations over a 48 hour period, no significant difference was observed among the 2-mL, 5-mL, and placebo groups. Although pain was lower in the 2 mL group, this observation was not statistically significant. Results indicated that the efficacy of infusion pumps is still unclear.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.